News
-
-
-
PRESS RELEASE
Pentixapharm AG Receives Orphan Drug Designation for its Radiodiagnostic Tracer PentixaFor in Marginal Zone Lymphoma by the European Medicines Agency
Pentixapharm AG receives orphan drug designation for radiodiagnostic tracer PentixaFor in Marginal Zone Lymphoma from the European Medicines Agency -
-
-
-
-
-
PRESS RELEASE
Pentixapharm Announces Expansion of Supervisory Board with the Appointment of Distinguished Endocrinologist Marcus Quinkler
Pentixapharm AG appoints distinguished endocrinologist Marcus Quinkler to its Supervisory Board. Quinkler's expertise in primary aldosteronism aligns with the company's focus on innovative radiopharmaceuticals